Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells

Eotaxin-1/CCL11, eotaxin-2/CCL24, and eotaxin-3/CCL26 bind specifically and exclusively to CC chemokine receptor (CCR) 3, which is a potential therapeutic target in treating the peribronchial eosinophilia associated with allergic airway diseases. Bronchial epithelial cells represent an important sou...

Full description

Saved in:
Bibliographic Details
Published inCellular immunology Vol. 225; no. 2; pp. 91 - 100
Main Authors Komiya, Akiko, Nagase, Hiroyuki, Yamada, Hirokazu, Sekiya, Takashi, Yamaguchi, Masao, Sano, Yasuyuki, Hanai, Nobuo, Furuya, Akiko, Ohta, Ken, Matsushima, Kouji, Yoshie, Osamu, Yamamoto, Kazuhiko, Hirai, Koichi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.10.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Eotaxin-1/CCL11, eotaxin-2/CCL24, and eotaxin-3/CCL26 bind specifically and exclusively to CC chemokine receptor (CCR) 3, which is a potential therapeutic target in treating the peribronchial eosinophilia associated with allergic airway diseases. Bronchial epithelial cells represent an important source of chemokines, and thus we investigated in vitro and in vivo expression of eotaxin-2 and eotaxin-3 in bronchial epithelial cells in comparison with that of eotaxin-1. Immunohistochemistry showed increased expression of both eotaxin-2 and eotaxin-3 in addition to eotaxin-1 in asthmatics. Considerable amounts of eotaxins were secreted by bronchial epithelial lineage. As with eotaxin-1 production, generation of eotaxin-2 and eotaxin-3 by bronchial epithelial cells was up-regulated by IL-4 and IL-13, and attenuated by IFN-γ and glucocorticoids. In addition to eotaxin-1 expression, but also eotaxin-2 and eotaxin-3 expression in the bronchial epithelium should be taken into consideration when developing the therapeutic strategies to treat eosinophilic airway diseases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0008-8749
1090-2163
DOI:10.1016/j.cellimm.2003.10.001